Hosted on MSN2h
Nearly 1.4 Million Over-the-Counter Eye Drops Recalled at FDA’s Highest Risk Level
A couple drops in your eye usually brings relief, not concern—but a rare recall case highlights the importance of a clean, sterile bottle.
Oculis Is An Interesting Growth Bet On Non-Invasive Eye Care
Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...
Livingston County News4d
FDA recalls popular eye drops for fungal contamination
Fort Worth, Texas-based Alcon Laboratories has voluntarily recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, which are packaged in batches of 25.
Healio13d
Brimochol PF achieves endpoints in second phase 3 presbyopia trial
Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 ...
bovnews1d
What’s Causing National Vision Holdings Inc (EYE) Stock’s -20.88% Drop Over the Last Six Months?
National Vision Holdings Inc (EYE) stock saw a modest uptick, ending the day at $10.8 which represents a slight increase of $0.05 or 0.47% from the prior close of $10.75. The stock opened at $11 and ...